Cetiedil citrate
Cetiedil citrate is a vasodilator and antihemolytic agent. Cetiedil citrate exerts anti-sickle cell anemia effects by blocking Ca2+-activated K+ channels (Gardos/KCa3.1). Cetiedil citrate is a muscarinic receptor antagonist that inhibits calcium-dependent release of acetylcholine (ACh) from mediated reconstituted proteoliposomes, with a Ki value of 5 μM. Cetiedil citrate possesses analgesic, spasmolytic and local anesthetic activities. Cetiedil citrate can be used in research related to ischemic leg pain caused by vascular diseases and sickle cell disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 16286-69-4
- Formule: C26H39NO9S
- Masse moléculaire:541.65
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform Calcium Channel
More
Activité biologique
Description
In Vitro
Cetiedil (10-50 μM; 2 h) citrate reduces electrically evoked ACh release from Torpedo marmorata electric organ slices in a concentration-dependent manner, without altering ACh synthesis or compartmentation at 50 μM[1].
Cetiedil (10 μM; 10 min) citrate does not affect ACh synthesis or endogenous ACh compartmentation in Torpedo marmorata electric organ synaptosomes, but it significantly reduces incorporation of newly synthesized radioactive ACh into synaptic vesicles[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 16286-69-4
-
Masse moléculaire 541.65
-
Formule C26H39NO9S
-
SMILES
O=C(OCCN1CCCCCC1)C(C2=CSC=C2)C3CCCCC3.OC(CC(C(O)=O)(O)CC(O)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1].
Gaudry-Talarmain YM, et al. Cetiedil, a drug that inhibits acetylcholine release in Torpedo electric organ. J Neurochem. 1987 Aug;49(2):548-54.
[Content Brief]
[2].
Abu-Salah KM, Gambo AH. An analysis of the mechanism by which cetiedil inhibits sickling. Life Sci. 2002 Jan 18;70(9):1003-11.
[Content Brief]
[3].
Roxburgh CJ, et al. The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil. J Pharm Pharmacol. 1996 Aug;48(8):851-7.
[Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Cetiedil
- 16286-69-4
- Potassium Channel
- Calcium Channel
- mAChR
- KcsA
- Ca2+ channels
- Ca channels
- Muscarinic acetylcholine receptor
- Torpedo marmorata
- acetylcholine
- mediatophore
- human erythrocyte membranes
- muscarinic receptor
- Na+,K+-ATPase
- Ca2+,Mg2+-ATPase
- sickle cell disease
- intestinal smooth muscle
- presynaptic membrane protein
- Inhibitor
- inhibitor
- inhibit